cbdMD Delivers on its Promise of Operating Improvement, adds Regulatory Depth to the BoardNewsfile Corp • 08/11/22
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2022, Third Quarter ResultsNewsfile Corp • 08/08/22
cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD ProductsNewsfile Corp • 06/29/22
cbdMD Leadership to Attend Mid-Atlantic Legislative Conference on June 1 in WVNewsfile Corp • 06/01/22
cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/17/22
CORRECTION FROM SOURCE: cbdMD, Inc. to Host Conference Call to Discuss March 31, 2022, Second Quarter ResultsNewsfile Corp • 05/06/22
cbdMD, Inc. to Host Conference Call to Discuss March 30, 2022, Second Quarter ResultsNewsfile Corp • 05/06/22
cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNCBusiness Wire • 03/03/22
cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD's Extensive Safety SubmissionBusiness Wire • 02/22/22
cbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards AgencyBusiness Wire • 02/17/22
cbdMD's (YCBD) CEO Marty Sumichrast on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/11/22
cbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out TargetBusiness Wire • 02/10/22
cbdMD Becomes The First CBD Company With NSF International's Certified For Sport CertificationBenzinga • 02/07/22